Litcius/Paper detail

Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial

Zifeng Yang, Yangqing Zhan, Zhengtu Li, Zhengshi Lin, Zhonghao Fang, Haijun Li, Xiaolin Chen, Banghan Ding, Huiqing Zeng, Xiuwei Zhang, Yudi Song, Zejun Lin, Shiwei Liang, Jincan Luo, Jufang Huang, Xiaoxin Chen, Nanshan Zhong, Xiaoxin Chen, Nanshan Zhong, Shuyue Xia, Gangfu Ye, Jie Peng, Xiaoguang Li, Xiaowei Xu, Lihong Qu, Xifu Wang, Ping Zhang, Zhijun Su, Zhen Tao, Min Pan, Hui Yang, Yingyun Fu, Yu Zhang, Hua Qiao, Limin Dong, Xiaoju Zhang, Ping Feng, Lei Shao, Xiansheng Liu

2025The Lancet Respiratory Medicine12 citationsDOI

Topics & Concepts

MedicineOseltamivirPlaceboDouble blindRandomized controlled trialInternal medicineEmergency medicinePhysical therapyIntensive care medicineCoronavirus disease 2019 (COVID-19)Alternative medicineDiseasePathologyInfectious disease (medical specialty)Influenza Virus Research StudiesRespiratory viral infections researchSARS-CoV-2 and COVID-19 Research
Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial | Litcius